No undesirable phenomena were registered in the postvaccinal period.
A. A. Ruleva, S. M. Kharit, E. P. Nacharova, I. V. Fridman 2013, 'EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN', Pediatričeskaâ Farmakologiâhttps://pf.spr-journal.ru/jour/article/view/255. Retrieved from DOAJ CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)
The postvaccinal period was uneventful in most cases.
S.M. Kharit, L.M. Lianko, O.V. Goleva, A.S. Kvetnaya, S.V. Petlenko, E.P. Nacharova,N.F. Snegova 2006, 'IMMUNIZATION AGAINST MEASLES AND DIPHTHERIA IN CHILDREN WITH HIV', Voprosy Sovremennoj Pediatriihttp://vsp.spr-journal.ru:80/jour/article/view/713. Retrieved from DOAJ CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)
We extracted data on the frequency of postvaccinal encephalitis and death with respect to vaccinia strain and age of vaccinees.
Mirjam Kretzschmar, Jacco Wallinga, Peter Teunis, Shuqin Xing, Rafael Mikolajczyk 2006, 'Frequency of adverse events after vaccination with different vaccinia strains.', PLoS Medicinehttp://europepmc.org/articles/PMC1551910?pdf=render. Retrieved from PLOS CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)